The abstract is read at the publisher; the summary is JClub's.
Andes virus (ANDV) is the sole orthohantavirus with documented human-to-human transmission, shaping how clinicians assess exposure risk and manage outbreaks.
- Why it matters: Human-to-human spread raises stakes for epidemiology, clinical recognition, and infection prevention, while treatment options remain uncertain and evolving.
- What they did: The review summarizes ANDV epidemiology and clinical features and evaluates clinical management best practices from expert consensus guidelines, field experience, and clinical trials, including antiviral agents and emerging monoclonal antibodies.
- The result: It consolidates evidence on currently available and investigational treatments and outlines prospects for vaccine development and infection prevention and control measures.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.